BING-JHEN HONG/iStock Editorial via Getty Images Reasons to continue buying TSM Despite the current dip since February 2026 peak levels, shares of Taiwan Semiconductor Manufacturing Company ( TSM ) delivered a total return of 31% since my September 2025 bullish call . The stock substantially outperformed compared to the broader market over the last six months, meaning that my bullishness aged well. And I think that the current 10% dip from late September levels is more likely temporary than structural. My confidence stems from the fact that TSM remains the cornerstone of the digital age. It is not just my subjective judgment, but a reality confirmed by the company's latest revenue report . During January-February of 2026, TSM's revenue soared by approximately 30% on a YoY basis, which is a huge increase considering TSM's scale. This is a substantial revenue growth acceleration compared to 25.5% YoY growth in Q4 2025 . Of course, in theory there might be deceleration in March 2026 sales, which can potentially drag down TSM's Q1 revenue growth. However, developments in the industry suggest that this scenario is highly unlikely. During the Q4 earnings season, all the largest cloud providers plus Meta unveiled their plans to significantly increase investments in data centers in FY2026. Very frequently we see announcements about large AI infrastructure projects breaking ground or one of the big tech firms investing in new AI startups. Moreover, during Nvidia's latest earnings call , Jensen Huang announced that sovereign AI is also a very rapidly growing area. Therefore, it is highly unlikely that TSM's revenue growth will decelerate notably in March 2026 and the company's Q1 sales are poised to accelerate notably compared to Q4 2025. And investors love accelerating revenue, especially when a company converts revenue growth into shareholder value. Seeking Alpha And TSM has absolutely no problem with converting revenue growth into profitability expansion. TSM's gross margi...

digidreamgrafix/iStock via Getty Images I have covered Western Midstream Partners LP ( WES ) before , where I explained the investment thesis in detail and why I considered it one of the most attractive buys within the midstream sector. Since the last article , the company released Q4 figures, which missed expectations but provided solid coverage numbers. It also renegotiated contracts with Occidental Petroleum ( OXY ), changing from a cost-of-service structure to a fixed-fee one. I’ll expand on it later but also recommend reading this article by fellow contributor Michael Boyd, which is focused on the transaction. Background Investor Presentation Western Midstream is a midstream operator focused mainly on gathering, processing, and transporting natural gas, with additional exposure to produced water handling. Its core operations are located in the Delaware Basin, where the company is concentrating its growth. Investor Presentation As discussed in my previous articles, produced water is becoming increasingly important in shale basins. In the Delaware Basin, up to 4.5 barrels of water are produced for every barrel of oil, and this water must be transported and disposed of. Western Midstream has been expanding its water business, especially with the acquisition of Aris Water Solutions , at the same time as its gas gathering and processing assets. Another important piece of news mentioned above is that the company recently announced the renegotiation of contracts with Occidental Petroleum , which is both its largest customer and its main shareholder. These new terms extend the duration of key contracts and improve visibility over future volumes in the Delaware Basin. On the other hand, the contracts change from a cost of service structure to a fixed fee one. Investor Presentation Usually, fixed fee structures are cheaper than cost-of-service ones. To compensate for the change in structure and as part of the renegotiation, Occidental transferred 15.3 million units (valu...

博硕科技（300951）公告，公司董事杨传奇先生因个人资金需求，通过集中竞价方式于2026年3月10日完成减持公司股份9800股，占公司总股本比例的0.006%。减持均价为38.98元/股。减持前，杨传奇持有公司股份39360股，减持后持股数为29560股。此次减持符合相关法律法规，未违反此前承诺，不影响公司控制权及持续经营。

Antonistock/iStock via Getty Images Introduction I’m bullish, in general. That’s no surprise, as I have written mostly bullish articles, and because my main thesis revolves around long-term broadening economic growth and a rotation into cyclical value stocks. However, as I’m still a strategist and not a cheerleader for my own portfolio, it’s part of my job to discuss the market more broadly, including risks that could derail my thesis and/or open up new opportunities, depending on how you look at it, of course. Especially in this market, I feel like someone threw a grenade into a chicken coop, as we’re all trying to figure out just how bad the Iran War can get and what this could mean for our portfolios. After all, even before the Iran War started, this was already a very tricky market. And, to be honest, this, once again, shows that the biggest forces of volatility are often the ones we do not expect. We (analysts, in general) spend hours every day making predictions, yet the events that have the biggest impact in the short term are missed by most. The 2020 pandemic could not have been predicted in 2019. The 2025 trade war escalated so fast that only insiders could have seen it coming. Tensions with Iran have been rising steadily, but the extent of the current war was nearly impossible to predict, especially not the timing. These are just three events, yet they are among the biggest volatility drivers in recent history. I didn’t predict a single one of them, and it doesn’t hurt my ego to say that. But that’s OK, as the same goes for most investors. What we need to do is be aware of the biggest market drivers and make sure we understand those. That’s what this article is about, as I’ll discuss a few risks and opportunities that are crucial to be on top of, especially as these risks involve the Fed. So, let’s get right to it! The Market’s Safety Net Is Weakening The past few years on the stock market were incredibly good, as most of you will know. We had one of the b...

Alistair Berg/DigitalVision via Getty Images When geopolitical tensions rise, currency markets are one of the first to react. In stressed markets, accessing diversified liquidity across venues becomes critical as implicit FX transaction costs can rise materially. We saw that again as tensions escalated in the Middle East . Currency markets adjusted almost immediately. Energy prices moved higher. Investors moved toward safe-haven currencies. Volatility picked up across both developed and emerging markets. In these periods, liquidity conditions can change quickly, where bid-offer spreads, an indication of implicit transaction costs for trading FX, can increase significantly. Market depth can also thin, making it more difficult to trade, with pricing that can vary meaningfully across trading venues. For global investors with FX trading and currency exposure management needs, this is precisely when execution quality matters most, and avoiding trading with a single counterparty or channel becomes critical. Liquidity fragments under pressure In stable conditions, liquidity in many developed and emerging market currency pairs can appear abundant. However, during stress events, liquidity fragments and as counterparties step back, risk appetite pricing can become less consistent. Following the recent Middle East escalation, developed market currency volatility moved materially above expectations, while emerging market currencies experienced even larger relative increases as investors repositioned toward the U.S. dollar and other defensive exposures. Volumes increased as investors flocked to safe haven currencies. Volatility climbed significantly as USD buying pressure rose, running around 40% higher in developed market currencies and almost 100% higher in emerging currencies versus expectations. We saw similar behavior at the start of the Russian invasion of Ukraine in 2022. Currency markets saw a significant increase in implicit transaction costs, with bid-ask spreads in th...

Completed Phase 1 pharmacokinetic (PK) clinical trial of denifanstat and resmetirom combination Phase 2 trial of denifanstat/resmetirom combination in F4 MASH patients planned to initiate in 2H 2026 Secured global, exclusive license to TAPI’s innovative forms of resmetirom active pharmaceutical ingredients (API) First-in-human Phase 1 clinical trial of FASN inhibitor TVB-3567 ongoing Positive topline results in open-label Phase 3 trial evaluating the long-term safety of denifanstat in patients with moderate to severe acne in China reported by Ascletis China’s National Medical Products Administration (NMPA) accepted Ascletis’ New Drug Application (NDA) for denifanstat for the treatment of moderate to severe acne SAN MATEO, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided recent corporate updates. “2025 saw important advances in both our MASH and acne programs,” said David Happel, Chief Executive Officer of Sagimet. “We completed our Phase 1 PK clinical trial of denifanstat and resmetirom combination and anticipate advancing the combination into a proof-of-concept Phase 2 clinical trial in F4 MASH, for which there are currently no approved treatments, in the second half of the year. In acne, positive 52-week data from our license partner Ascletis’ Phase 3 open-label acne trial with denifanstat will support Ascletis’ NDA that was accepted by the Chinese NMPA. We anticipate further exploring the potential role of FASN inhibition in acne in clinical development in 2026.” Recent Corporate Highlights Clinical and Regulatory Updates In December 2025, Sagimet announced the completion of its open-label Phase 1 pharmacokinetic (PK) clinical trial of its oral once-daily fatty acid synthase (FASN) inhibitor, de...

Q4 Revenue Grew 27% Year-Over-Year to Record $14.5 Million Q4 Operating Income of $1.9 Million; Adjusted EBITDA Increased by 53% to $2.3 Million, Reflecting Significant Operating Leverage Full Year 2025 Revenue Increased by Approximately 27% YoY to $52.2 Million, and Net Income Increased by Approximately 161% YoY to $7.6 Million Remaining Performance Obligations Increased 43% to Approximately $70 Million Issuing 2026 Guidance: Expecting Revenue of $66 - $68 million (27% - 30% Growth), Operating Income of 13% - 14%, and Adjusted EBITDA of $12 - $14 Million (86% - 100% Growth) Conference Call to be Held Today at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, March 11, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today reported fourth quarter and full year 2025 financial results and provided an operational update. Recent Financial and Operational Highlights Revenue in the fourth quarter of 2025 increased 27% to $14.5 million, compared with the fourth quarter of 2024. Approximately 70% of customer engagements signed in recent quarters are structured as multi-year lease agreements. Increased remaining performance obligations to approximately $70 million, representing a 43% increase compared with December 31, 2024. Shipped a net total of 95 Deep TMS™ systems during the fourth quarter of 2025, a 27% increase compared with the same period last year. Total installed base now stands at approximately 1,700 systems. Gross margin for the fourth quarter of 2025 was 76%, compared with 75% in the prior year period. Operating income for the fourth quarter of 2025 was $1.9 million, compared with $0.4 million for the prior year period. Adjusted EBITDA 1 for the fourth quarter of 2025 increased 53% to $2.3 million, compared with $1.5 million for the fourth quarter of 2024. for the fourth quarter of 2025 increased 53% to $2.3 million, compared wi...

Some investors can't stomach the volatility of high-flying tech stocks. But this is a walk in the park compared to the extremely wild nature of the cryptocurrency market. Shiba Inu (SHIB 0.96%) is the perfect representation. Its price skyrocketed a mind-boggling 102,000,000% from the start of 2021 to its all-time high in late October that year, according to data from CoinGecko. Asset prices shouldn't move like that, indicating heightened excesses. That enthusiasm didn't last long, though, and now this token trades more than 90% below the peak (as of March 5). As tempting as it might be to buy on the dip, here are three reasons why I'm avoiding Shiba Inu in 2026. 1. Shiba Inu is past its prime Shiba Inu isn't always a money-losing opportunity. There are instances when its price quickly jumps based on hype. But these don't last very long. This isn't a situation that is deserving of investors' hard-earned money. Speculators can, in theory, buy and sell at the right times to capture profits. This is a surefire way to lose money, though, as no one can successfully do this on a consistent basis. And given that Shiba Inu's price has been in a downward spiral for years now, the community of supporters backing it appears to be losing interest. Expand CRYPTO : SHIB Shiba Inu Today's Change ( -0.96 %) $ -0.00 Current Price $ 0.00 Key Data Points Market Cap $3.3B Day's Range $ 0.00 - $ 0.00 52wk Range $ 0.00 - $ 0.00 Volume 219M 2. Fundamental weakness Eventually, I believe a cryptocurrency has to prove that it actually solves a problem. If the market believes that it doesn't, the value will likely trend toward zero. Shiba Inu might fall into this bucket. It's not on the list of the top 100 blockchains based on developer activity. With a seemingly low number of developers, the probability of introducing applications that could boost utility is very low. To its credit, Shiba Inu has a metaverse, decentralized exchange, and Layer-2 scaling solution in place. Despite these innovat...

China’s spring hiring season is revealing a sharp surge in demand for artificial intelligence talent as companies speed up the deployment of related technologies, turning it into one of the country’s hottest professional fields. The number of AI-related job postings in China in the first two months of the year grew about 12-fold year on year, far outpacing growth in other “new-economy” industries such as healthcare, renewable energy and semiconductors, People’s Daily reported on Tuesday, citing insights from a report by professional social networking platform Maimai. AI-related jobs accounted for 26.23 per cent of all new-economy job postings, up from just 2.29 per cent a year ago, Maimai said, signalling that Chinese companies were rapidly integrating AI into core business operations. Advertisement Some specialised positions remain particularly hard to fill. The supply-demand ratio for high-performance computing engineers was just 0.15, meaning around seven positions were competing for each candidate. Other technical roles, including those for creators of simultaneous localisation and mapping algorithms, regulatory control algorithms and cloud computing functions, also face significant shortages. Salaries reflect the scarcity of AI talent. Online recruitment platform Zhaopin.com reported this week that AI engineers command an average monthly salary of 20,804 yuan (US$3,020), ranking highest among tech jobs – above chip engineers , mobile developers and software engineers. Advertisement

Nemes Rush Group LLC cut its stake in shares of Advanced Micro Devices, Inc. (NASDAQ:AMD - Free Report) by 41.8% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 6,661 shares of the semiconductor manufacturer's stock after selling 4,782 shares during the period. Nemes Rush Group LLC's holdings in Advanced Micro Devices were worth $1,078,000 as of its most recent SEC filing. Get Advanced Micro Devices alerts: Sign Up Other hedge funds also recently added to or reduced their stakes in the company. Norges Bank acquired a new stake in Advanced Micro Devices in the second quarter valued at $3,094,662,000. Jennison Associates LLC acquired a new position in shares of Advanced Micro Devices during the 3rd quarter worth $626,826,000. Nordea Investment Management AB grew its stake in shares of Advanced Micro Devices by 203.7% during the 3rd quarter. Nordea Investment Management AB now owns 3,905,148 shares of the semiconductor manufacturer's stock worth $631,892,000 after purchasing an additional 2,619,294 shares during the period. Rafferty Asset Management LLC increased its holdings in shares of Advanced Micro Devices by 56.0% in the 2nd quarter. Rafferty Asset Management LLC now owns 6,772,923 shares of the semiconductor manufacturer's stock valued at $961,078,000 after purchasing an additional 2,430,533 shares in the last quarter. Finally, Vanguard Group Inc. increased its holdings in shares of Advanced Micro Devices by 1.5% in the 2nd quarter. Vanguard Group Inc. now owns 154,648,859 shares of the semiconductor manufacturer's stock valued at $21,944,673,000 after purchasing an additional 2,281,508 shares in the last quarter. 71.34% of the stock is owned by institutional investors and hedge funds. Advanced Micro Devices Stock Performance NASDAQ:AMD opened at $203.23 on Wednesday. The company has a current ratio of 2.85, a quick ratio of 2.01 and a debt-to-equity ratio of 0.04. The company has a...

Kepler Cheuvreux Suisse SA purchased a new stake in Alphabet Inc. (NASDAQ:GOOG - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 68,201 shares of the information services provider's stock, valued at approximately $16,610,000. Get Alphabet alerts: Sign Up Several other large investors also recently made changes to their positions in GOOG. Robinson Smith Wealth Advisors LLC lifted its position in Alphabet by 1.8% in the 3rd quarter. Robinson Smith Wealth Advisors LLC now owns 2,070 shares of the information services provider's stock valued at $504,000 after acquiring an additional 36 shares in the last quarter. Searle & CO. increased its holdings in Alphabet by 0.6% during the 3rd quarter. Searle & CO. now owns 5,703 shares of the information services provider's stock worth $1,389,000 after purchasing an additional 36 shares in the last quarter. Navellier & Associates Inc. raised its stake in shares of Alphabet by 0.6% in the 3rd quarter. Navellier & Associates Inc. now owns 5,846 shares of the information services provider's stock valued at $1,424,000 after purchasing an additional 36 shares during the period. BankPlus Wealth Management LLC raised its stake in shares of Alphabet by 1.2% in the 3rd quarter. BankPlus Wealth Management LLC now owns 3,143 shares of the information services provider's stock valued at $766,000 after purchasing an additional 37 shares during the period. Finally, Activest Wealth Management lifted its holdings in shares of Alphabet by 0.5% in the third quarter. Activest Wealth Management now owns 7,997 shares of the information services provider's stock valued at $1,948,000 after purchasing an additional 38 shares in the last quarter. Institutional investors own 27.26% of the company's stock. Alphabet Price Performance NASDAQ:GOOG opened at $306.93 on Wednesday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 2....

Nemes Rush Group LLC grew its holdings in shares of Tesla, Inc. (NASDAQ:TSLA - Free Report) by 64.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 34,447 shares of the electric vehicle producer's stock after purchasing an additional 13,477 shares during the period. Tesla accounts for 1.5% of Nemes Rush Group LLC's portfolio, making the stock its 21st biggest position. Nemes Rush Group LLC's holdings in Tesla were worth $15,319,000 as of its most recent SEC filing. Get Tesla alerts: Sign Up A number of other large investors also recently modified their holdings of the business. Chapman Financial Group LLC acquired a new stake in Tesla during the second quarter worth about $26,000. Manning & Napier Advisors LLC acquired a new position in Tesla in the third quarter valued at approximately $29,000. CoreFirst Bank & Trust acquired a new position in Tesla in the second quarter valued at approximately $30,000. ESL Trust Services LLC grew its holdings in shares of Tesla by 1,900.0% during the second quarter. ESL Trust Services LLC now owns 100 shares of the electric vehicle producer's stock valued at $32,000 after purchasing an additional 95 shares during the last quarter. Finally, Delos Wealth Advisors LLC acquired a new stake in shares of Tesla during the 2nd quarter worth approximately $32,000. 66.20% of the stock is currently owned by institutional investors. Insider Buying and Selling In other Tesla news, CFO Vaibhav Taneja sold 2,264 shares of the firm's stock in a transaction dated Friday, March 6th. The shares were sold at an average price of $397.03, for a total transaction of $898,875.92. Following the transaction, the chief financial officer owned 18,106 shares of the company's stock, valued at approximately $7,188,625.18. This trade represents a 11.11% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Di...

53,470 Shares in Broadcom Inc. $AVGO Acquired by Kepler Cheuvreux Suisse SA MarketBeat

Kepler Cheuvreux Suisse SA bought a new position in Tesla, Inc. (NASDAQ:TSLA - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The fund bought 15,562 shares of the electric vehicle producer's stock, valued at approximately $6,921,000. Get Tesla alerts: Sign Up Several other large investors have also recently modified their holdings of TSLA. Norges Bank bought a new position in Tesla in the 2nd quarter worth about $11,839,824,000. Vanguard Group Inc. raised its stake in shares of Tesla by 1.8% during the second quarter. Vanguard Group Inc. now owns 251,390,681 shares of the electric vehicle producer's stock valued at $79,856,764,000 after acquiring an additional 4,502,976 shares in the last quarter. Amundi raised its stake in shares of Tesla by 20.4% during the second quarter. Amundi now owns 20,194,152 shares of the electric vehicle producer's stock valued at $6,374,284,000 after acquiring an additional 3,422,270 shares in the last quarter. Jennison Associates LLC grew its stake in Tesla by 38.3% in the third quarter. Jennison Associates LLC now owns 10,909,666 shares of the electric vehicle producer's stock worth $4,851,747,000 after purchasing an additional 3,021,550 shares in the last quarter. Finally, Capital World Investors increased its holdings in Tesla by 5.8% during the 3rd quarter. Capital World Investors now owns 44,035,949 shares of the electric vehicle producer's stock worth $19,583,547,000 after purchasing an additional 2,403,019 shares during the period. Institutional investors own 66.20% of the company's stock. Key Headlines Impacting Tesla Here are the key news stories impacting Tesla this week: Tesla Price Performance TSLA opened at $399.23 on Wednesday. The firm has a market capitalization of $1.50 trillion, a PE ratio of 369.66, a price-to-earnings-growth ratio of 11.79 and a beta of 1.89. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.16 and a quick ratio of 1.77. The busi...

Nemes Rush Group LLC increased its position in shares of Oracle Corporation (NYSE:ORCL - Free Report) by 103.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,430 shares of the enterprise software provider's stock after acquiring an additional 20,575 shares during the quarter. Oracle accounts for about 1.1% of Nemes Rush Group LLC's holdings, making the stock its 28th largest position. Nemes Rush Group LLC's holdings in Oracle were worth $11,371,000 at the end of the most recent reporting period. Get Oracle alerts: Sign Up Other hedge funds have also made changes to their positions in the company. Norges Bank purchased a new position in Oracle during the 2nd quarter worth approximately $4,275,378,000. Jennison Associates LLC lifted its holdings in shares of Oracle by 2,062.4% in the third quarter. Jennison Associates LLC now owns 9,227,252 shares of the enterprise software provider's stock valued at $2,595,072,000 after purchasing an additional 8,800,546 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Oracle by 2.8% in the third quarter. Vanguard Group Inc. now owns 168,960,500 shares of the enterprise software provider's stock valued at $47,518,451,000 after purchasing an additional 4,681,626 shares in the last quarter. American Century Companies Inc. boosted its position in shares of Oracle by 333.7% in the third quarter. American Century Companies Inc. now owns 5,238,006 shares of the enterprise software provider's stock worth $1,473,137,000 after buying an additional 4,030,382 shares during the period. Finally, Invesco Ltd. boosted its position in shares of Oracle by 42.1% in the second quarter. Invesco Ltd. now owns 8,839,166 shares of the enterprise software provider's stock worth $1,932,507,000 after buying an additional 2,619,722 shares during the period. Hedge funds and other institutional investors own 42.44% of the company's stock....

Kepler Cheuvreux Suisse SA bought a new stake in shares of Qualcomm Incorporated (NASDAQ:QCOM - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 47,466 shares of the wireless technology company's stock, valued at approximately $7,896,000. Get Qualcomm alerts: Sign Up A number of other institutional investors have also recently made changes to their positions in QCOM. Harbor Capital Advisors Inc. grew its position in Qualcomm by 72.2% in the third quarter. Harbor Capital Advisors Inc. now owns 155 shares of the wireless technology company's stock worth $26,000 after acquiring an additional 65 shares in the last quarter. Cloud Capital Management LLC purchased a new stake in Qualcomm during the third quarter valued at approximately $27,000. Winnow Wealth LLC purchased a new stake in Qualcomm in the 2nd quarter valued at about $32,000. Lavaca Capital LLC bought a new position in Qualcomm in the 2nd quarter worth about $32,000. Finally, Howard Hughes Medical Institute purchased a new position in shares of Qualcomm during the second quarter worth approximately $38,000. Institutional investors own 74.35% of the company's stock. More Qualcomm News Here are the key news stories impacting Qualcomm this week: Wall Street Analysts Forecast Growth Several analysts have recently weighed in on QCOM shares. Cantor Fitzgerald decreased their price target on shares of Qualcomm from $185.00 to $160.00 and set a "neutral" rating for the company in a research note on Monday, February 2nd. Rosenblatt Securities dropped their price objective on Qualcomm from $225.00 to $190.00 and set a "buy" rating on the stock in a research note on Thursday, February 5th. Royal Bank Of Canada reduced their price objective on Qualcomm from $180.00 to $150.00 and set a "sector perform" rating on the stock in a report on Thursday, February 5th. Loop Capital raised Qualcomm from a "hold" rating to a "b...

Nemes Rush Group LLC Trims Stock Holdings in Broadcom Inc. $AVGO MarketBeat

In the wake of discourse surrounding Teyana Taylor’s Perfidia in One Battle After Another, a familiar debate has resurfaced about what happens when Black women play morally ambiguous characters on screen In one scene in Paul Thomas Anderson’s One Battle After Another, Teyana Taylor’s character, Perfidia Beverly Hills, is more focused on seducing Leonardo DiCaprio’s Bob Ferguson (then still known as “Ghetto Pat”) than on the bomb exploding just feet away from them. In another scene, she holds Sean Penn’s Steven J Lockjaw at gunpoint while simultaneously provoking an erection. These are some of the perceived brazen, morally slippery choices Perfidia makes that have unsettled some viewers since the movie’s premiere. “I absolutely hate what this means for the representation of Black women in Hollywood,” YouTuber and cultural commentator Jouelzy said in a video posted a day after Taylor won the Golden Globe award for best supporting actress. “So often the institutional powers that be only reward us for portrayals that are stereotypical characters of Black women. One Battle After Another was such an offensive film.” Continue reading...

欧盟批准对多个伊朗官员和实体实施制裁。欧盟外交与安全政策高级代表卡拉斯11日表示，欧盟成员国当天批准了针对伊朗19名官员和实体的新制裁措施。（央视新闻）

格隆汇3月11日｜光线传媒在互动平台表示，公司在业务实践中会针对不同的使用场景选择适配的包括但不限于Seedance2.0在内的多种不同的视频生成模型。

财联社3月11日讯（编辑 王蔚） 中小银行理财今年末清零整改或生变，多家银行的理财人士受访，对财联社如此表示。 今年以来，中小银行已发行1598只公募理财产品，以封闭式为主，产品到期日多在2027年之前。 不过，财联社近期观察发现，包括浙江富阳农村商业银行、昆仑银行、临商银行、广东南粤银行、西安银行、长沙银行、大连银行、湖北银行、中原银行、广西北部湾银行等在内的多家银行，发行的部分封闭式理财产品到期日在2027年及之后，这被市场看作是清零整改放松信号。 此前于2024年，监管对未成立理财公司的银行理财业务风险做出提醒，要求部分省份相关城商行与农商行于2026年末将存量理财业务全部清理完毕。 2025年，整改成效显著。据中国理财网披露数据，截至2025 年末，全国共有 159 家银行机构和 32 家理财公司有存续的理财产品，相较于2024年末，发行银行减少了59家。 离原先市场预期的今年末整改大限不足10个月，为何还有银行热衷于自行发行理财产品？ “自去年起，监管部门一直在淡化压降清零的口风，目前监管态度不明，未明确要清零，各家银行都采取观望态度。”财联社向某新发行理财产品（到期日在2027年及之后）的银行资管部门人士征询为何新发产品，该负责人对财联社如此表示，该行虽在新发，不过总体规模是微降。 一家北部的银行资管部门负责人对财联社称，今年是否会有新的理财公司获监管部门批设是重要信号，若有新批，则未批设的中小银行理财大概率会清零。该人士透露，原本由国家金融监督管理总局批设理财子，目前还要上报至中央金融委员会办公室，难度增大。 年底清零不明？今年是否新设理财公司是重要信号 据中国理财网披露数据，今年以来，中小银行并未停止理财产品的发行步伐。 中国理财网数据显示，今年以来，中小银行已发行1598只公募理财产品，以封闭式为主，产品到期日多在2027年之前。不过，据财联社梳理，包括浙江富阳农村商业银行、昆仑银行、临商银行、广东南粤银行、西安银行、长沙银行、大连银行、湖北银行、中原银行、广西北部湾银行等在内的多家银行，发行的封闭式理财产品到期日在2027年及之后。 如浙江富阳农村商业银行股份有限公司丰收富盈“颐享”2026年第626期人民币理财产品，采取封闭运作，产品结束日期为2027/10/12。 仍有银行新发理财产品，显示出各家机构对监管的试探、观望态度。 某北部的银行资管...

格隆汇3月11日｜英国财政大臣里夫斯：预算和支出的优先投入领域是国家医疗服务体系(NHS)和国防。

AppLovin Corporation (NASDAQ:APP) is one of the stocks on which Jim Cramer expressed his thoughts. A caller asked if the “AI ad platform” is still alive, and in response, Cramer said: Too much risk there. I do fear that, kind of like what happened with Trade Desk, you come in, you wake up, and Google’s there. I don’t want Google to be coming in after me. And I think the margins there are so good that who knows what will happen. Photo by Artem Podrez on Pexels AppLovin Corporation (NASDAQ:APP) provides a software platform that helps advertisers and app developers market and monetize their content. The company offers advertising solutions, analytics tools, connected TV services, and mobile games. Cramer called it a “former market darling” during the February 6 episode as he remarked: You know what the market doesn’t like? How about AppLovin, which is a former market darling from the year of magical investing? Not so magical now that Google’s decided to crowd into that space. While we acknowledge the potential of APP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. Follow Insider Monkey on Google News.

格隆汇3月11日｜华东医药公告，公司全资子公司杭州中美华东制药有限公司收到美国食品药品监督管理局（以下简称“美国FDA”）通知，由中美华东申报的注射用HDM2024药品临床试验申请已获得美国FDA批准，可在美国开展I期临床试验，适应症为晚期实体瘤。

Oracle Corporation (NYSE:ORCL) is one of the stocks on which Jim Cramer expressed his thoughts. Cramer highlighted the company’s data center business, as he stated: Now, today was an important day. It showed you that when oil’s in reverse, you get huge buying in what, the semiconductor stocks like Broadcom, Micron, and NVIDIA. It’s an amazing thing to see because there was no catalyst today, just a sense that, well, you’re being given one more chance to get in before the data center theme takes off again. Under any circumstances, I would wait to see how Oracle acts if you do want to find out about data centers. Oracle has made itself the king of the data center. It’s the fastest-growing in the space. We need to hear that there’s still tremendous demand for data centers from more than just the hyperscalers and that new chips from NVIDIA are going to be fabulous. Oracle can help us with that. A laptop and a computer monitor display a detailed stock market technical analysis chart. Photo by Jakub Zerdzicki on Pexels Oracle Corporation (NYSE:ORCL) provides cloud and on-premise software, databases, and IT infrastructure to help businesses manage operations. While we acknowledge the potential of ORCL as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. Follow Insider Monkey on Google News.

Jim Cramer Says “Oracle Has Made Itself the King of the Data Center, It’s the Fastest-Growing In the Space” Yahoo Finance

Private equity investors would have been better off parking their money in the public markets over the last five years, even when gains from the so-called Magnificent 7 stocks are stripped out, a new report shows. The asset class has underperformed major public benchmarks over the last one, three and five years, with or without the Mag 7 included, according to the 2026 Market Overview from private capital manager Hamilton Lane Inc. The Mag 7 refers to a group of technology companies including Apple Inc. , Microsoft Corp. and Meta Platforms Inc. , whose growth has powered equity market performance in recent years amid the shift from a human to machine-driven global economy. Buyout firm’s inability to outperform even stock benchmarks that exclude those tech gains will be a worry for investors who have poured billions of dollars into private equity, and paid high fees, on the promise of greater returns. Richard Hope , co-head of investments and head of Europe, the Middle East and Africa at Hamilton Lane, said private equity remained an important way for investors to diversify their allocations. “We’re not hiding from the fact that there has been underperformance,” Hope said in an interview. “We’re saying it’s a diversified play. You can’t ignore it and you should have some in your portfolio because of public markets already being at 99 percentile of returns.” ‘Structural Change’ Hamilton Lane’s findings arrive with private equity firms already struggling to return capital to investors. A recent report from Bain & Co. found that the industry delivered fewer profits to investors for a fourth straight year in 2025. Meanwhile, there are growing concerns that private equity firms could get stuck with more hard-to-sell assets as they try to start offloading companies bought for rich valuations during the pandemic dealmaking boom. Many of those companies have since seen their business models challenged by AI, while higher interest rates have contributed to a valuation gap bet...

格隆汇3月11日｜瑞泰新材(301238.SZ)发布投资者关系活动记录表公告，公司在固态电池、半固态电池等新型电池材料方面持续性地进行了相关的研发投入与积累。公司生产的双三氟甲基磺酰亚胺锂（LiTFSI）用途较广泛，其在固态锂离子电池等新型电池也已形成批量销售，公司已与国内外多家固态电池相关企业开展合作。目前双三氟甲基磺酰亚胺锂（LITFSI）的整体市场需求较充足，公司正在逐步扩产中。另外，公司也在持续开发其他固态电池材料，其中部分固态电解质产品已完成小试开发。

jetcityimage/iStock Editorial via Getty Images Announcing the submission of a marketing application for its experimental weight loss drug, orforglipron, in China, Eli Lilly ( LLY ) said on Wednesday that it plans to invest $3B in the country over the next decade to expand its supply chain capacity there. In a statement on the Chinese social media site WeChat, the Indiana-based drugmaker said that a major component of the investment is building the local production capacity for its pipeline, including orforglipron. The company added that it filed a marketing application for the once-daily GLP-1 drug with the National Medical Products Administration late last year. Concurrently, Lilly ( LLY ) announced a collaboration with Beijing-based contract research and manufacturing firm Pharmaron to invest $200M to enhance its technological capabilities. Orforglipron, a competitor to Novo Nordisk’s ( NVO ) recently launched oral weight loss therapy, the Wegovy pill, is currently undergoing FDA review in the U.S. and is on track for a potential approval in Q2 2026. More on Eli Lilly CagriSema Incident: The Surprise Winner And What It Means For The Novo-Lilly Rivalry Eli Lilly: The One-Way Ride Can't Last Forever (Rating Downgrade) Eli Lilly and Company (LLY) Presents at TD Cowen 46th Annual Health Care Conference Transcript Hims & Hers hires former Lilly communications chief Lilly says GLP-1 access for some Medicare members could exceed $50 monthly cap

Will the real chief executive officer of Nestlé SA please stand up? On LinkedIn that is. Laurent Freixe ’s profile on LinkedIn still shows him as CEO more than six months after he was fired by the Swiss food company for not disclosing an internal office romance. Philipp Navratil , who really does run Nestlé, is also named on the world’s largest professional networking platform as CEO of the maker of KitKat chocolate and Nespresso capsules. Freixe’s profile boasts nearly 64,000 followers — a good 20,000 more than Navratil’s — and until the beginning of March he was also listed as a “Top Voice,” a designation given on an invitation-only basis by LinkedIn for leaders in their field. Navratil still has his “Top Voice” accreditation. Last year’s ouster of Freixe from Nestlé was the highest-profile board spat in Switzerland since then-Credit Suisse Chairman Urs Rohner fired Tidjane Thiam amid a spying scandal. Freixe was dismissed without an exit package and had his phone seized without notice or opportunity to secure his communication tools — including to, say, update his LinkedIn profile. A few days after he was pushed out Freixe, 63, wrote on LinkedIn that he had managed to recover his access and directed a post to his successor Navratil and Nestlé staff wishing them well. However, since then his profile has not been updated to reflect that he has left the company. Freixe did not respond to repeated requests for comment via his LinkedIn account. Changes to LinkedIn profiles are typically made voluntarily by executives themselves. Last month, when Sanofi’s former CEO Paul Hudson was ousted, for example, his LinkedIn page was updated almost immediately to reflect the transition, underscoring how such digital resumes publicly signal leadership changes. Nestlé has asked Freixe to change his profile, which was previously managed by the company’s corporate communications team, and provided him with all information needed to access his account, according to a person familiar ...